Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02378896 · ClinicalTrials.gov registry record · NA

Personalized Computerized Inhibitory Control Training for OCD

A NA study of Obsessive - Compulsive Disorder, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT02378896: Completed NA study of Obsessive - Compulsive Disorder, sponsored by New York State Psychiatric Institute.

NCT02378896 is a NA study of Obsessive - Compulsive Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 11 participants, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02378896, a NA study of Obsessive - Compulsive Disorder, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.

Primary Outcome

measured by Yale Brown Obsessive Compulsive Scale (YBOCS)

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy
  • BEHAVIORAL Personalized Computer Program

Study Locations (1)

New York

  • New York State Psychiactic Institute - New York

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2015-02
Est. Completion 2018-01
Phase NA

What the finished NCT02378896 record still lists

NCT02378896 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.

NCT02378896 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02378896 about?

NCT02378896 is a clinical study titled "Personalized Computerized Inhibitory Control Training for OCD". This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.

What is the current status of trial NCT02378896?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2015-02. Estimated completion is 2018-01.

What conditions does trial NCT02378896 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT02378896?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Personalized Computer Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02378896?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02378896 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02378896's enrollment target sits among peer trials

11 76th of 84 higher than 9 of 84 other Obsessive - Compulsive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02378896, the US trial registry maintained by the National Library of Medicine. NCT02378896 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.